Relay Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Relay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
  • Relay Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$101M, a 4.99% increase year-over-year.
  • Relay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$357M, a 2.48% increase year-over-year.
  • Relay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$373M, a 24.6% decline from 2022.
  • Relay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$299M, a 17.9% increase from 2021.
  • Relay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$365M, a 554% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$357M -$101M +$5.29M +4.99% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$362M -$90.4M +$10.8M +10.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$373M -$92.2M -$19.3M -26.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$354M -$73.6M +$12.3M +14.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$366M -$106M -$28.2M -36.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$338M -$101M -$38.5M -61.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$299M -$72.9M -$5.13M -7.57% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$294M -$85.9M -$24.9M -40.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$269M -$77.8M +$116M +59.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$385M -$62.7M -$20.3M -47.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$365M -$67.7M -$103M -294% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 -$262M -$61M -$24.4M -66.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$238M -$194M -$166M -598% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$71.7M -$42.4M -$15.9M -60.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$55.8M $35M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$36.6M -$14.7M -67.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$27.7M -$7.81M -39.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$26.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 -$21.9M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$19.9M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.